Effect of silymarin and its polyphenolic fraction on cholesterol absorption in rats
Jazyk angličtina Země Nizozemsko Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
16275123
DOI
10.1016/j.phrs.2005.09.004
PII: S1043-6618(05)00162-3
Knihovny.cz E-zdroje
- MeSH
- antioxidancia farmakologie MeSH
- azetidiny farmakologie MeSH
- cholesterol dietní farmakokinetika MeSH
- cholestyraminová pryskyřice farmakologie MeSH
- ezetimib MeSH
- fenoly farmakologie MeSH
- flavonoidy farmakologie MeSH
- intestinální absorpce účinky léků MeSH
- játra účinky léků metabolismus MeSH
- krysa rodu Rattus MeSH
- lipoproteiny VLDL krev MeSH
- lipoproteiny metabolismus MeSH
- polyfenoly MeSH
- silymarin farmakologie MeSH
- triglyceridy farmakologie MeSH
- zvířata MeSH
- Check Tag
- krysa rodu Rattus MeSH
- mužské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- antioxidancia MeSH
- azetidiny MeSH
- cholesterol dietní MeSH
- cholestyraminová pryskyřice MeSH
- ezetimib MeSH
- fenoly MeSH
- flavonoidy MeSH
- lipoproteiny VLDL MeSH
- lipoproteiny MeSH
- polyfenoly MeSH
- silymarin MeSH
- triglyceridy MeSH
This study evaluated the influence of silymarin (SM) and polyphenolic fraction (PF) of silymarin on cholesterol absorption in rats fed on high cholesterol diet (HCD). HCD induced a remarkable increase in hepatic, plasma, VLDL and LDL cholesterol, a decrease in HDL cholesterol and an elevation in triacylglycerol (TAG) levels in plasma, VLDL and in the liver. SM and PF were administered as dietary supplements (1.0%) in HCD for 18 days. Intestinal cholesterol absorption was measured by dual-isotope plasma ratio method, which calculates percent of cholesterol absorption from the ratio of two labelled cholesterol doses, one given intragastrically (14C) and one intravenously (3H). Silymarin and PF significantly reduced cholesterol absorption in rats fed on HCD and caused significant decreases in plasma and VLDL cholesterol and content of cholesterol and TAG in the liver. The level of HDL cholesterol was significantly increased after silymarin, but not after administration of PF. The levels of TAG in plasma and VLDL were not affected by either silymarin or PF. These results suggest that the inhibition of cholesterol absorption caused by silymarin and its polyphenolic fraction could be a mechanism contributing to the positive changes in plasma cholesterol lipoprotein profile and in lipid content in liver.
Citace poskytuje Crossref.org